SK Bioscience to Invest 150 bln Won to Beef Up Vaccine Production Capacity
SEOUL, June 21 (Korea Bizwire) — SK Bioscience Co., a major South Korean pharmaceutical firm, said Monday it plans to invest 150 billion won (US$132 million) through 2024 to expand its production capacity of COVID-19 vaccines. SK Bioscience said the investment is meant to increase the production capacity of the production line based in Andong, [...]